SKU: SUG-TB-3.3-150
In StockSugavive MV3.3 is a triple oral anti-diabetic formulation used for the comprehensive management of Type 2 Diabetes Mellitus.
Dosage
As directed by the Physician
Pack Size
15 Tablet(s) per Strip
Sugavive MV3.3 is a triple oral anti-diabetic formulation used for the comprehensive management of Type 2 Diabetes Mellitus. It is typically prescribed when blood glucose levels are not adequately controlled by diet, exercise, or dual-drug therapy. Here is the pharmacological breakdown of how the three components work together: 1.Glimepiride (3 mg): A sulfonylurea that acts as an insulin secretagogue. It lowers blood glucose by directly stimulating the beta cells in the pancreas to release more insulin. 2.Metformin SR (500 mg): A biguanide that primarily targets insulin resistance. It reduces hepatic (liver) glucose production and increases peripheral glucose uptake. The SR (Sustained Release) formulation ensures the drug is released gradually into the system, which maintains steady blood levels and significantly reduces gastrointestinal side effects like nausea or diarrhea. 3.Voglibose (0.3 mg): An alpha-glucosidase inhibitor. It works in the intestine to delay the digestion and absorption of complex carbohydrates. This specifically flattens the curve of postprandial (post-meal) blood sugar spikes.
Send us an enquiry and we'll get back to you within 24 hours.